Results 201 to 210 of about 40,056 (270)

Cytisinicline vs. Varenicline in Tobacco Addiction: A Literature Review Focused on Emotional Regulation, Psychological Symptoms, and Mental Health. [PDF]

Healthcare (Basel)
Fraile-Martínez Ó, García-Montero C, Ortega MA, Varaona A, Gutiérrez-Rojas L, Álvarez-Mon M, Álvarez-Mon MÁ.   +6 more
europepmc   +1 more source

Therapeutic Targeting of the α7 Nicotinic Receptor: Challenges and Prospects for Cognitive Improvement in Alzheimer's and Schizophrenia. [PDF]

Basic Clin Pharmacol Toxicol
Magnussen JH.
europepmc   +1 more source

HSV1 glycoprotein D utilizes an LY6-like binding domain to inhibit alpha7 nicotinic receptors. [PDF]

Npj Viruses
Yeasmin S, Sharma K, Nicolet C, DeCristofano L, Ataian Y, Ranjit A, Aghazadeh-Habashi A, Xu D, Schulte M.   +8 more
europepmc   +1 more source

The ATP-mediated cytokine release by macrophages is down-modulated by unconventional α9* nicotinic acetylcholine receptors. [PDF]

Front Immunol
Wolf PMK, Hanke D, Singh VK, Keller HL, Ettischer LJ, Teppe L, Amati AL, Hecker A, Husain-Syed F, Rohde M, Nuber UA, Büttner K, McIntosh JM, Liese J, Mazurek S, Grau V, Richter K.   +16 more
europepmc   +1 more source

Understanding varenicline function via key receptor and ligand interactions.

Cell Rep Phys Sci
Aiken SG, Fiorito D, Harper M, Pikus G, Underhill J, Murray J, Rawlinson J, O'Donoghue AC, Gotti C, Lummis SCR, Minguez Viñas T, Viscarra F, Bermudez I, Gallagher T, Oliveira ASF.   +14 more
europepmc   +1 more source

Curcumin Derivatives as Allosteric Modulator of α7-nAChR: Functional and Molecular Docking Insights. [PDF]

Med Princ Pract
ElNebrisi E, Ghattas MA, Atatreh N, Hasan S, Oz M.   +4 more
europepmc   +1 more source

α7 nicotinic acetylcholine receptor agonist attenuates lipopolysaccharide-induced acute kidney injury in mice by reducing CCL2 expression in macrophages. [PDF]

Sci Rep
Matsuo S, Uni R, Wu CH, Nakamura Y, Umene R, Surattichaiyakul B, Nangaku M, Inagi R, Nishino T, Inoue T.   +9 more
europepmc   +1 more source

Amantadine-based combination therapy of Parkinson's disease to prevent fluctuation and dyskinesia - experiences from a Parkinson outpatient clinic. [PDF]

Front Aging Neurosci
Oehlwein C, Netzel L, Mittmann K, Oehlwein M, Schulz-Schaeffer WJ.   +4 more
europepmc   +1 more source

The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson's Disease. [PDF]

Int J Mol Sci
ElNebrisi E, Lozon Y, Oz M.
europepmc   +1 more source

Toxicity, Chemistry, and Public Health Relevance of Emerging Nicotine Analog Vapes, Pods, and Pouches. [PDF]

Chem Res Toxicol
Raghu R, Sengupta M, Lin K, Effah F, Strongin RM, Rahman I.   +5 more
europepmc   +1 more source